semaglutide compound effectiveness TrimRX Compounded Semaglutide Effectiveness vs FDA

223 GumbsAA

What are the main side effects

Retatrutide is currently still being evaluated in Phase 3 clinical trials, which means healthcare providers cannot yet prescribe it.[2] The drug is being developed by Eli Lilly and is being studied for potential treatment of obesity, type 2 diabetes, and fatty liver disease

What makes retatrutide different from other GLP-1s is that its a triple agonist, sometimes nicknamed triple G, because it targets three hormone pathways at the same time: GLP-1 (glucagon-like peptide-1): Found naturally in your gut, this hormone helps lower blood sugar by triggering insulin release and slowing down how fast food moves through the stomach, so you feel fuller for longer